report cover

Latent TB Infection Testing Market, Global Outlook and Forecast 2023-2030

  • 25 November 2023
  • Life Sciences
  • 65 Pages
  • Report code : 24WT-7860221

Latent TB Infection Testing and Forecast Market

1 Introduction to Research & Analysis Reports
1.1 Latent TB Infection Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Latent TB Infection Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Latent TB Infection Testing Overall Market Size
2.1 Global Latent TB Infection Testing Market Size: 2022 VS 2030
2.2 Global Latent TB Infection Testing Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Latent TB Infection Testing Players in Global Market
3.2 Top Global Latent TB Infection Testing Companies Ranked by Revenue
3.3 Global Latent TB Infection Testing Revenue by Companies
3.4 Top 3 and Top 5 Latent TB Infection Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Latent TB Infection Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Latent TB Infection Testing Players in Global Market
3.6.1 List of Global Tier 1 Latent TB Infection Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Latent TB Infection Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Latent TB Infection Testing Market Size Markets, 2022 & 2030
4.1.2 Mantoux Test / Tuberculin Skin Test (TST)
4.1.3 Interferon-Gamma Release Assay (IGRA)
4.2 By Type - Global Latent TB Infection Testing Revenue & Forecasts
4.2.1 By Type - Global Latent TB Infection Testing Revenue, 2018-2023
4.2.2 By Type - Global Latent TB Infection Testing Revenue, 2024-2030
4.2.3 By Type - Global Latent TB Infection Testing Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Latent TB Infection Testing Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Public and Student Health
5.1.4 Physician Offices and Clinics
5.1.5 Others (Military, Correctional Facilities, Chronic Care Homes, and Others)
5.2 By Application - Global Latent TB Infection Testing Revenue & Forecasts
5.2.1 By Application - Global Latent TB Infection Testing Revenue, 2018-2023
5.2.2 By Application - Global Latent TB Infection Testing Revenue, 2024-2030
5.2.3 By Application - Global Latent TB Infection Testing Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Latent TB Infection Testing Market Size, 2022 & 2030
6.2 By Region - Global Latent TB Infection Testing Revenue & Forecasts
6.2.1 By Region - Global Latent TB Infection Testing Revenue, 2018-2023
6.2.2 By Region - Global Latent TB Infection Testing Revenue, 2024-2030
6.2.3 By Region - Global Latent TB Infection Testing Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Latent TB Infection Testing Revenue, 2018-2030
6.3.2 US Latent TB Infection Testing Market Size, 2018-2030
6.3.3 Canada Latent TB Infection Testing Market Size, 2018-2030
6.3.4 Mexico Latent TB Infection Testing Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Latent TB Infection Testing Revenue, 2018-2030
6.4.2 Germany Latent TB Infection Testing Market Size, 2018-2030
6.4.3 France Latent TB Infection Testing Market Size, 2018-2030
6.4.4 U.K. Latent TB Infection Testing Market Size, 2018-2030
6.4.5 Italy Latent TB Infection Testing Market Size, 2018-2030
6.4.6 Russia Latent TB Infection Testing Market Size, 2018-2030
6.4.7 Nordic Countries Latent TB Infection Testing Market Size, 2018-2030
6.4.8 Benelux Latent TB Infection Testing Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Latent TB Infection Testing Revenue, 2018-2030
6.5.2 China Latent TB Infection Testing Market Size, 2018-2030
6.5.3 Japan Latent TB Infection Testing Market Size, 2018-2030
6.5.4 South Korea Latent TB Infection Testing Market Size, 2018-2030
6.5.5 Southeast Asia Latent TB Infection Testing Market Size, 2018-2030
6.5.6 India Latent TB Infection Testing Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Latent TB Infection Testing Revenue, 2018-2030
6.6.2 Brazil Latent TB Infection Testing Market Size, 2018-2030
6.6.3 Argentina Latent TB Infection Testing Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Latent TB Infection Testing Revenue, 2018-2030
6.7.2 Turkey Latent TB Infection Testing Market Size, 2018-2030
6.7.3 Israel Latent TB Infection Testing Market Size, 2018-2030
6.7.4 Saudi Arabia Latent TB Infection Testing Market Size, 2018-2030
6.7.5 UAE Latent TB Infection Testing Market Size, 2018-2030
7 Latent TB Infection Testing Companies Profiles
7.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC)
7.1.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Company Summary
7.1.2 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Business Overview
7.1.3 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Major Product Offerings
7.1.4 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Revenue in Global Market (2018-2023)
7.1.5 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Key News & Latest Developments
7.2 Pharmstandard (Generium Pharmaceutical)
7.2.1 Pharmstandard (Generium Pharmaceutical) Company Summary
7.2.2 Pharmstandard (Generium Pharmaceutical) Business Overview
7.2.3 Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Major Product Offerings
7.2.4 Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Revenue in Global Market (2018-2023)
7.2.5 Pharmstandard (Generium Pharmaceutical) Key News & Latest Developments
7.3 Sanofi S.A./Sanofi Pasteur Ltd.
7.3.1 Sanofi S.A./Sanofi Pasteur Ltd. Company Summary
7.3.2 Sanofi S.A./Sanofi Pasteur Ltd. Business Overview
7.3.3 Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Major Product Offerings
7.3.4 Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Revenue in Global Market (2018-2023)
7.3.5 Sanofi S.A./Sanofi Pasteur Ltd. Key News & Latest Developments
7.4 Statens Serum Institut (SSI)
7.4.1 Statens Serum Institut (SSI) Company Summary
7.4.2 Statens Serum Institut (SSI) Business Overview
7.4.3 Statens Serum Institut (SSI) Latent TB Infection Testing Major Product Offerings
7.4.4 Statens Serum Institut (SSI) Latent TB Infection Testing Revenue in Global Market (2018-2023)
7.4.5 Statens Serum Institut (SSI) Key News & Latest Developments
7.5 Autoimmun Diagnostika (AID) GmbH
7.5.1 Autoimmun Diagnostika (AID) GmbH Company Summary
7.5.2 Autoimmun Diagnostika (AID) GmbH Business Overview
7.5.3 Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Major Product Offerings
7.5.4 Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Revenue in Global Market (2018-2023)
7.5.5 Autoimmun Diagnostika (AID) GmbH Key News & Latest Developments
7.6 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.
7.6.1 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Company Summary
7.6.2 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Business Overview
7.6.3 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Major Product Offerings
7.6.4 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Revenue in Global Market (2018-2023)
7.6.5 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Key News & Latest Developments
7.7 Haikou VTI Biological Institute (Vaccine Technologies, Inc.)
7.7.1 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Company Summary
7.7.2 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Business Overview
7.7.3 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Major Product Offerings
7.7.4 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Revenue in Global Market (2018-2023)
7.7.5 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Key News & Latest Developments
7.8 Immunoshop India Pvt. Ltd.
7.8.1 Immunoshop India Pvt. Ltd. Company Summary
7.8.2 Immunoshop India Pvt. Ltd. Business Overview
7.8.3 Immunoshop India Pvt. Ltd. Latent TB Infection Testing Major Product Offerings
7.8.4 Immunoshop India Pvt. Ltd. Latent TB Infection Testing Revenue in Global Market (2018-2023)
7.8.5 Immunoshop India Pvt. Ltd. Key News & Latest Developments
7.9 Qiagen N.V.
7.9.1 Qiagen N.V. Company Summary
7.9.2 Qiagen N.V. Business Overview
7.9.3 Qiagen N.V. Latent TB Infection Testing Major Product Offerings
7.9.4 Qiagen N.V. Latent TB Infection Testing Revenue in Global Market (2018-2023)
7.9.5 Qiagen N.V. Key News & Latest Developments
7.10 Quest Diagnostics, Inc. (Oxford Immunotec Global plc)
7.10.1 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Company Summary
7.10.2 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Business Overview
7.10.3 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Major Product Offerings
7.10.4 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Revenue in Global Market (2018-2023)
7.10.5 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Key News & Latest Developments
7.11 SD Biosensor, Inc.
7.11.1 SD Biosensor, Inc. Company Summary
7.11.2 SD Biosensor, Inc. Business Overview
7.11.3 SD Biosensor, Inc. Latent TB Infection Testing Major Product Offerings
7.11.4 SD Biosensor, Inc. Latent TB Infection Testing Revenue in Global Market (2018-2023)
7.11.5 SD Biosensor, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. Latent TB Infection Testing Market Opportunities & Trends in Global Market
Table 2. Latent TB Infection Testing Market Drivers in Global Market
Table 3. Latent TB Infection Testing Market Restraints in Global Market
Table 4. Key Players of Latent TB Infection Testing in Global Market
Table 5. Top Latent TB Infection Testing Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Latent TB Infection Testing Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Latent TB Infection Testing Revenue Share by Companies, 2018-2023
Table 8. Global Companies Latent TB Infection Testing Product Type
Table 9. List of Global Tier 1 Latent TB Infection Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Latent TB Infection Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Latent TB Infection Testing Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Latent TB Infection Testing Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Latent TB Infection Testing Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Latent TB Infection Testing Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Latent TB Infection Testing Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Latent TB Infection Testing Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Latent TB Infection Testing Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Latent TB Infection Testing Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Latent TB Infection Testing Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Latent TB Infection Testing Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Latent TB Infection Testing Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Latent TB Infection Testing Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Latent TB Infection Testing Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Latent TB Infection Testing Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Latent TB Infection Testing Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Latent TB Infection Testing Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Latent TB Infection Testing Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Latent TB Infection Testing Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Latent TB Infection Testing Revenue, (US$, Mn), 2024-2030
Table 30. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Company Summary
Table 31. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Product Offerings
Table 32. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Revenue (US$, Mn) & (2018-2023)
Table 33. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Key News & Latest Developments
Table 34. Pharmstandard (Generium Pharmaceutical) Company Summary
Table 35. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Product Offerings
Table 36. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Revenue (US$, Mn) & (2018-2023)
Table 37. Pharmstandard (Generium Pharmaceutical) Key News & Latest Developments
Table 38. Sanofi S.A./Sanofi Pasteur Ltd. Company Summary
Table 39. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Product Offerings
Table 40. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Revenue (US$, Mn) & (2018-2023)
Table 41. Sanofi S.A./Sanofi Pasteur Ltd. Key News & Latest Developments
Table 42. Statens Serum Institut (SSI) Company Summary
Table 43. Statens Serum Institut (SSI) Latent TB Infection Testing Product Offerings
Table 44. Statens Serum Institut (SSI) Latent TB Infection Testing Revenue (US$, Mn) & (2018-2023)
Table 45. Statens Serum Institut (SSI) Key News & Latest Developments
Table 46. Autoimmun Diagnostika (AID) GmbH Company Summary
Table 47. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Product Offerings
Table 48. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Revenue (US$, Mn) & (2018-2023)
Table 49. Autoimmun Diagnostika (AID) GmbH Key News & Latest Developments
Table 50. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Company Summary
Table 51. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Product Offerings
Table 52. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Revenue (US$, Mn) & (2018-2023)
Table 53. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Key News & Latest Developments
Table 54. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Company Summary
Table 55. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Product Offerings
Table 56. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Revenue (US$, Mn) & (2018-2023)
Table 57. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Key News & Latest Developments
Table 58. Immunoshop India Pvt. Ltd. Company Summary
Table 59. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Product Offerings
Table 60. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Revenue (US$, Mn) & (2018-2023)
Table 61. Immunoshop India Pvt. Ltd. Key News & Latest Developments
Table 62. Qiagen N.V. Company Summary
Table 63. Qiagen N.V. Latent TB Infection Testing Product Offerings
Table 64. Qiagen N.V. Latent TB Infection Testing Revenue (US$, Mn) & (2018-2023)
Table 65. Qiagen N.V. Key News & Latest Developments
Table 66. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Company Summary
Table 67. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Product Offerings
Table 68. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Revenue (US$, Mn) & (2018-2023)
Table 69. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Key News & Latest Developments
Table 70. SD Biosensor, Inc. Company Summary
Table 71. SD Biosensor, Inc. Latent TB Infection Testing Product Offerings
Table 72. SD Biosensor, Inc. Latent TB Infection Testing Revenue (US$, Mn) & (2018-2023)
Table 73. SD Biosensor, Inc. Key News & Latest Developments
List of Figures
Figure 1. Latent TB Infection Testing Segment by Type in 2022
Figure 2. Latent TB Infection Testing Segment by Application in 2022
Figure 3. Global Latent TB Infection Testing Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Latent TB Infection Testing Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Latent TB Infection Testing Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Latent TB Infection Testing Revenue in 2022
Figure 8. By Type - Global Latent TB Infection Testing Revenue Market Share, 2018-2030
Figure 9. By Application - Global Latent TB Infection Testing Revenue Market Share, 2018-2030
Figure 10. By Type - Global Latent TB Infection Testing Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Latent TB Infection Testing Revenue Market Share, 2018-2030
Figure 12. By Application - Global Latent TB Infection Testing Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Latent TB Infection Testing Revenue Market Share, 2018-2030
Figure 14. By Region - Global Latent TB Infection Testing Revenue Market Share, 2018-2030
Figure 15. By Country - North America Latent TB Infection Testing Revenue Market Share, 2018-2030
Figure 16. US Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Latent TB Infection Testing Revenue Market Share, 2018-2030
Figure 20. Germany Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 21. France Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Latent TB Infection Testing Revenue Market Share, 2018-2030
Figure 28. China Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 32. India Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Latent TB Infection Testing Revenue Market Share, 2018-2030
Figure 34. Brazil Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Latent TB Infection Testing Revenue Market Share, 2018-2030
Figure 37. Turkey Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Latent TB Infection Testing Revenue, (US$, Mn), 2018-2030
Figure 41. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Statens Serum Institut (SSI) Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Qiagen N.V. Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. SD Biosensor, Inc. Latent TB Infection Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Latent TB Infection Testing and Forecast Market

Leave This Empty: